Published January 30, 2021 | Version CC BY-NC-ND 4.0
Journal article Open

A Novel Method for Drug Repositioning Based on Heterogeneous Network

Creators

  • 1. Department of Computer Science and Engineering, Mar Athanasius College of Engineering, Kothamangalam, Kerala, India
  • 2. Department of Computer Science and Engineering, Mar Athanasius College of Engineering, Kothamangalam, Kerala, India.

Contributors

Contact person:

  • 1. Department of Computer Science and Engineering, Mar Athanasius College of Engineering, Kothamangalam, Kerala, India.

Description

Abstract: Drug repositioning is a compelling technique to find new signs for existing medications. Despite the fact that few exploration have attempted to improve the precision of repositioning by joining information from more than one assets and various levels, it is as yet appealing to additionally review how to effectively abuse significant information for drug repositioning. As contrasted and the customary medication improvement from particle to item, drug repositioning is additional time and worth effective, quickening drug revelation technique. Medication repositioning methods might be ordered as both sicknesses based or drug-based. In this study at, propose an effective strategy, by means of utilizing Adverse Drug Reactions (ADRs) in light of the fact that the middle of the road, a heterogeneous wellbeing network containing drugs, infections, proteins and ADRs is constructed. The repositioning procedure dependent on ADR is equipped for profiling drugs related phenotypic information and can accordingly aid the resulting drugs utilize the disclosure of new recuperating

Notes

Published By: Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP) © Copyright: All rights reserved.

Files

E5206019521.pdf

Files (649.1 kB)

Name Size Download all
md5:6875247783b5e69804b9f6e750f3f135
649.1 kB Preview Download

Additional details

Related works

Is cited by
Journal article: 2277-3878 (ISSN)

References

  • DiMasi, J. A., Grabowski, H. G., Hansen, R. W. (2015). The cost of drug development. New England Journal of Medicine, 372(20), 1972- 1972.
  • Ashburn, T. T., Thor, K. B. (2004). Drug repositioning: identifying and developing new uses for existing drugs. Nature reviews Drug discovery, 3(8), 673-683.
  • Gilbert, J., Henske, P., Singh, A. (2003). Rebuilding big pharma's business model. IN VIVO-NEW YORK THEN NORWALK-, 21(10), 73-80.
  • Boguski MS et al. Science. 2009 324: 1394 [PMID: 19520944]
  • Chiang AP Butte AJ, Clin Pharmacol Ther. 2009 86: 507 [PMID: 19571805]
  • Yang L Agarwal P, PLoS One. 2012 6: e28025 [PMID: 22205936]
  • Cheng F et al. PLoS Comput Biol. 2012 8: e1002503 [PMID: 22589709]
  • Ye, H., Liu, Q., Wei, J. (2014). Construction of drug network based on side effects and its application for drug repositioning. PloS one, 9(2), e87864.
  • Dudley, J. T., Deshpande, T., Butte, A. J. (2011). Exploiting drug–disease relationships for computational drug repositioning. Brief- ings in bioinformatics, 12(4), 303-311.
  • Li, J., Zheng, S., Chen, B., Butte, A. J., Swamidass, S. J., Lu, Z. (2015). A survey of current trends in computational drug repositioning. Briefings in Bioinformatics, 17(1), 2-12.
  • Y. Fukuoka, D. Takei, H. Ogawa, A two-step drug repositioning method based on a protein-protein interaction network of genes shared by two diseases and the similarity of drugs, Bioinformation 9 (2013) 089e093.
  • Ashburn, T. T., Thor, K. B. (2004). Drug repositioning: identifying and developing new uses for existing drugs. Nature reviews Drug discovery, 3(8), 673-683.
  • Zhang, M., Luo, H., Xi, Z., Rogaeva, E. (2015). Drug Repositioning for Diabetes Based on'Omics' Data Mining. PloS one, 10(5), e0126082.
  • Kim, T. W. (2015). Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer's Disease. Neurotherapeutics, 12(1), 132-142.
  • Jiang, W., Chen, X., Liao, M., Li, W., Lian, B., Wang, L., ... Li, X. (2012). Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses. Scientific reports, 2.
  • Iorio, F., Rittman, T., Ge, H., Menden, M., Saez-Rodriguez, J. (2013). Transcriptional data: a new gateway to drug repositioning?. Drug discovery today, 18(7), 350-357.
  • Rukov, J. L., Wilentzik, R., Jaffe, I., Vinther, J., Shomron, N. (2013). Pharmaco-miR: linking microRNAs and drug effects. Briefings in bioin- formatics, bbs082.
  • Okada, Y., Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., ... Graham, R. R. (2014). Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature, 506(7488), 376-381.
  • Ng, C. L. A. R. A., Hauptman, R. U. T. H., Zhang, Y.I. N. L. I. A. N. G., Bourne, P. E., Xie, L. (2014). Anti-infectious drug repurposing using an integrated chemical genomics and structural systems biology approach. InPac Symp Biocomput (Vol. 19, pp. 136-147).
  • Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen,, S. J., ... Whaley, R. (2009). Predicting new molecular targets for known drugs.Nature, 462(7270), 175-181.
  • Li, J., Lu, Z. (2012, October). A new method for computational drug repositioning using drug pairwise similarity. In Bioinformatics and Biomedicine (BIBM), 2012 IEEE International Conference On (pp. 1-4). IEEE.
  • Tan, F., Yang, R., Xu, X., Chen, X., Wang, Y., Ma, H., ... Jia, X. (2014). Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity. Molecular BioSystems, 10(5), 1126-1138.
  • Zheng, C., Guo, Z., Huang, C., Wu, Z., Li, Y., Chen, X., ... Wang, Y. (2015). Large-scale Direct Targeting for Drug Repositioning and Discovery. Scientific reports, 5.
  • Kinnings, S. L., Liu, N., Buchmeier, N., Tonge, P. J., Xie, L., Bourne, P. (2009). Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput Biol, 5(7), e1000423.
  • Zhang, M., Luo, H., Xi, Z., Rogaeva, E. (2015). Drug Repositioning for Diabetes Based on'Omics' Data Mining. PloS one, 10(5), e0126082.
  • Kim, T. W. (2015). Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer's Disease. Neurotherapeutics, 12(1), 132-142.
  • Chiang, A. P., Butte, A. J. (2009). Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clinical pharmacology and therapeutics, 86(5), 507.
  • Suthram, S., Dudley, J. T., Chiang, A. P., Chen, R., Hastie, T. J., Butte,J. (2010). Networkbased elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput Biol, 6(2), e1000662.
  • Nugent, T., Plachouras, V., Leidner, J. L. (2016). Computational drug repositioning based on sideeffects mined from social media. PeerJ Computer Science, 2, e46.
  • Wu, C., Gudivada, R. C., Aronow, B. J., Jegga, A. G. (2013). Computational drug repositioning through heterogeneous network clus- tering.BMC systems biology, 7(Suppl 5), S6.

Subjects

ISSN: 2277-3878 (Online)
https://portal.issn.org/resource/ISSN/2277-3878
Retrieval Number: 100.1/ijrte.E5206019521
https://www.ijrte.org/portfolio-item/E5206019521/
Journal Website: www.ijrte.org
https://www.ijrte.org/
Publisher: Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP)
https://www.blueeyesintelligence.org/